DSGN · NASDAQ
Design Therapeutics (DSGN) Stock Price & Fundamentals
Design Therapeutics (DSGN) closed at $696.65 on Oct 9, 2026, up 1.21% from the previous close of $688.33.
Share price, past year
1Y +31.63%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $696.65 |
| Sep 30, 2026 | $678.29 |
| Aug 31, 2026 | $696.72 |
| Jul 31, 2026 | $679.40 |
| Jun 30, 2026 | $620.91 |
| May 29, 2026 | $572.70 |
| Apr 30, 2026 | $563.94 |
| Mar 31, 2026 | $559.72 |
| Feb 27, 2026 | $576.24 |
| Jan 30, 2026 | $544.10 |
| Dec 31, 2025 | $531.87 |
| Nov 28, 2025 | $533.23 |
| Oct 31, 2025 | $532.30 |
Key statistics
- Market cap
- $43.60B
- P/E (TTM)
- —
- EPS (TTM)
- −$1.18
- Revenue (TTM)
- —
- Net income (TTM)
- −$70.80M
- Shares outstanding
- 62.6M
- Dividend yield
- —
- 52-week range
- $517.84 – $712.98
Design Therapeutics's market cap is $43.60B, based on a share price of $696.65 and 62.6M shares outstanding as of Jun 30, 2026.
Financials
Design Therapeutics reported revenue of $0.00 for fiscal 2025.
Design Therapeutics reported a net loss of $69.79M in fiscal 2025.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2025ended Dec 31, 2025 | $0.00 | — | −$69.79M | — | −$1.22 | −$54.55M |
| FY2024ended Dec 31, 2024 | $0.00 | −100.0% | −$49.59M | — | −$0.88 | −$43.45M |
| FY2020ended Dec 31, 2020 | $226.00K | — | −$8.28M | −3,663.7% | −$0.52 | −$8.75M |
| Quarter | Revenue | Net income | EPS (diluted) |
|---|---|---|---|
| Q1 FY2026ended Mar 31, 2026 | $0.00 | −$17.64M | −$0.29 |
| Q1 FY2025ended Mar 31, 2025 | $0.00 | −$17.72M | −$0.31 |
| Q4 FY2020ended Dec 31, 2020 | $33.00K | — | — |
| Q3 FY2020ended Sep 30, 2020 | $20.00K | — | — |
| Q2 FY2020ended Jun 30, 2020 | $31.00K | — | — |
| Q1 FY2020ended Mar 31, 2020 | $142.00K | — | — |
Company profile
- Name
- Design Therapeutics, Inc.
- Ticker
- DSGN
- Exchange
- NASDAQ
- Industry (SEC SIC)
- Pharmaceutical Preparations
- Headquarters
- 6005 Hidden Valley Road, Suite 110, Carlsbad, CA 92011
- Incorporated in
- DE
- Fiscal year ends
- December
- SEC CIK
- 0001807120
Recent SEC filings
- Aug 3, 2026
- Aug 3, 2026
- Jun 11, 2026
- May 18, 2026
- Apr 28, 2026
- Apr 28, 2026
- Apr 1, 2026
- Mar 9, 2026
Frequently asked questions
What is Design Therapeutics's stock price?
Design Therapeutics (DSGN) closed at $696.65 on Oct 9, 2026, up 1.21% from the previous close of $688.33.
What is Design Therapeutics's market cap?
Design Therapeutics's market cap is $43.60B, based on a share price of $696.65 and 62.6M shares outstanding as of Jun 30, 2026.
How much revenue does Design Therapeutics make?
Design Therapeutics reported revenue of $0.00 for fiscal 2025.
Does Design Therapeutics pay a dividend?
Design Therapeutics's recent filings report no dividends declared over the last four quarters.
Sources and methodology
Fundamentals come from Design Therapeutics, Inc.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures